Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta Receptor Modulation in V-A ECMO
NCT06522594Phase 2Recruiting
- Sponsor
- Erasmus MC
- Start
- Jun 2024
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of esmolol in cardiogenic shock, sponsored by Erasmus MC. Started Jun 2024; status: recruiting.
02
Drugs
esmolol
03
Conditions
cardiogenic shock
Beyond the preview
Go deeper on NCT06522594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06522594.